Print Page  |  Contact Us  |  Sign In  |  Register
EAS 2016 Scientific Abstracts
Share |

84th EAS Congress Session details

Poster Walk   
Lipoproteins and Lipid Metabolism: Lp(a) (click blue links below to see full abstract).

Kristall Foyer    Date: Monday, May 30, 2016    From: 17:00    To: 18:00
 


 
 
 
 
17:00 - 18:00 PROGNOSTIC VALUE OF COMBINED LIPOPROTEIN(A) AND HOMOCYSTEINE IN ANGIOGRAPHICALLY PROVEN PATIENTS WITH CORONARY ARTERY DISEASE  188
  S.W. Kwon1, H.M. Kwon2
1Inha University Hospital, Department of Cardiology, Incheon, Republic of Korea
2Gangnam Severance Hospital, Cardiology, Seoul, Republic of Korea
 
17:00 - 18:00 LIPOPROTEIN(A) MEASUREMENT AND ASSOCIATION WITH MEDICAL HISTORY IN SECONDARY CARE LIPID CLINICS  189
  K.E. Shipman1, A.J. Lawson2, W. Alkaaby1, A.F. Jones2, R. Cramb1
1University Hospital Birmingham, Department of Clinical Chemistry, Birmingham, United Kingdom
2Birmingham Heartlands Hospital, Department of Biochemistry and Immunology, Birmingham, United Kingdom
 
17:00 - 18:00 ELEVATED LIPOPROTEIN(A) AND ISCHEMIC STROKES- A CASE REPORT  190
  P. Moriarty1, N. Sehar1, L. Denney1, F. Perez-Marques2, A. Panchal2, P. Luna2
1University Of Kansas Medical Center, Clinical Pharmacology, Kansas City, USA
2University Of Kansas Medical Center, Pediatrics, Kansas City, USA
 
17:00 - 18:00 RATIONALE AND DESIGN OF A CLINICAL TRIAL TO ASSESS LP(A) LOWERING WITH IONIS-APO(A)-LRX IN PATIENTS UNDERGOING APHERESIS FOR ELEVATED LP(A) AND RECURRENT CARDIOVASCULAR EVENTS  191
  P.M. Moriarty 1, E.S. Thiessen 2, J.L. Witztum 3, N.J. Viney 4, S. Tsimikas 5
1University of Kansas Medical Center, Clinical Pharmacology, Kansas City, USA
2Charite-Universitaetsm edizin, LIpid Ambulatory Clinic, Berlin, Germany
3UCSD, Endocrinology, La Jolla, USA
4Ionis Pharmaceuticals, Pharmaceuticals, Carlsbad, USA
5, USA
 
17:00 - 18:00 PREVALENCE OF LPA SINGLE NUCLEOTIDE POLYMORPHISMS AND ISOFORMS IN PATIENTS ENROLLED IN A PHASE 2 IONIS-APO(a)Rx CLINICAL TRIAL  192
  E.S. Stroes 1, F.M. van der Valk1, D. Gaudet 2, I. Gouni-Berthold3, N.P. Riksen4, E. Steinhagen-Thiessen5, B. Isermann6, B. Nordestgaard7, N.J. Viney8, S. Marcovina9, S.G. Hughes8, J. Tami10, S. Xia11, J.L. Witztum12, S. Tsimikas13
1Academic Medical Center- Amsterdam, Medicine, Amsterdam, Netherlands
2Universite de Montreal and Ecogene-21 Clinical Reserach centre, Medicine, Chicoutimi, Canada
3University of Cologne, Medicine, Cologne, Germany
4Rabdoud University Medical Centre, Medicine, Nijmegen, Netherlands
5Lipid Ambulatory clinic- Charite-Universitaetsm edizin, Medicine, Berlin, Germany
66Institut für klinische chemie und Biochemie- Lipidambulanz- Germany, Medicine, Magdeburg, Germany
7Herlev Hospital- Copenhagen University Hospital- University of Copenhagen- Denmark, Medicine, Copenhagen, Denmark
8Ionis Pharmaceuticals- Carlsbad- CA, Pharmaceuticals, Carlsbad, USA
9University of Washington- Seattle- WA, Medicine, Seattle, USA
10Ionis Pharmaceuticals, Pharmaceuticals, Carlesbad, USA
11Ionis Pharmaceuticals, Pharmaceuticals, Carlsbad, USA
12UCSD, Medicine/endocrinology, LA JOLLA, USA
13, USA
 
17:00 - 18:00 NATURAL TEMPORAL VARIABILITY IN Lp(a) LEVELS IN PATIENTS ENROLLED IN THE PLACEBO ARMS OF IONIS-APO(a)Rx ANTISENSE OLIGONUCLEOTIDE CLINICAL TRIALS  193
  N.J. Viney1, S. Marcovina 2, J. Tami3, S. Xia 3, J.L. Witztum4, S. Tsimikas5
1Ionis Pharmaceuticals, Pharmaceuticals, Carlsbad, USA
2University of Washington- Seattle- WA, Medicine, Seattle, USA
3Ionis Pharmaceuticals, Pharmaceutical, Carlsbad, USA
4UCSD, Medicine/endocrinology, La Jolla, USA
5, USA
 
17:00 - 18:00 PROGNOSTIC VALUE OF SERUM LIPOPROTEIN(A) LEVELS ON LONG-TERM MORTALITY IN A LARGE SAMPLE OF SUBJECTS IN PRIMARY CARDIOVASCULAR PREVENTION: DATA FROM THE BRISIGHELLA HEART STUDY  194
  F. Fogacci1, S. D'Addato1, A.F.G. Cicero1, E. Bertagnin1, S. Palmisano1, L. D'Agostini1, E. Grandi1, M. Giovannini1, C. Borghi1
1Alma Mater Studiorum University of Bologna, Department of Medical and Surgical Sciences, Bologna, Italy
 
17:00 - 18:00 A SYSTEMATIC REVIEW AND META-ANALYSIS COMPARING THE EFFECTS OF STATINS AND FIBRATES ON PLASMA LIPOPROTEIN(A) LEVELS  195
  A. Sahebkar1, L.E. Simental-Mendía2, M. Banach3, M.C. Serban4, G.F. Watts5
1Mashhad University of Medical Sciences, Biotechnology Research Center, Mashhad, Iran
2Mexican Social Security Institute, Biomedical Research Unit-, Durango, Mexico
3Medical University of Lodz, Department of Hypertension, Lodz, Poland
4“Victor Babes” University of Medicine and Pharmacy, Department of Functional Sciences, Timisoara, Romania
5Lipid Disorders Clinic- Royal Perth Hospital- School of Medicine and Pharmacology- University of Western Australia, Cardiovascular Medicine, Perth, Australia
 
17:00 - 18:00 DEFINING THE MECHANISM OF LIPOPROTEIN(A) [LP(A)] LOWERING BY ALIROCUMAB IN TRANSGENIC MOUSE MODELS  196
  C. Yeang1, P. Miu1, S. Green1, X. Yang1, M.Y. Hung2, J.L. Witztum1, S. Tsimikas1
1University of California - San Diego, Medicine, San Diego, USA
2Taipei Medical University, Medicine, Taipei, Taiwan
 
17:00 - 18:00 LIPOPROTEIN(A)-CHOLESTEROL (LP(A)-C) LEVELS DETERMINED BY VERTICAL AUTO PROFILE (VAP) CORRELATES WEAKLY WITH LP(A) MASS BUT MODESTLY WITH HDL-C: IMPLICATIONS FOR APPROPRIATE INTERPRETATION OF CLINICAL DATA  197
  C. Yeang1, S. Tsimikas1
1University of California - San Diego, Medicine, San Diego, USA
 
17:00 - 18:00 LIPOPROTEIN(a) AND INSULIN RESISTANCE: A POSSIBLE INVERSE RELATIONSHIP BETWEEN TWO WELL-KNOWN CARDIOVASCULAR RISK FACTORS  198
  C.O. Aragona1, E. Imbalzano1, V. Cairo1, F. Mamone1, A. Lo Gullo1, M.A. Sardo1, A. Saitta1, G. Mandraffino1
1University of Messina, Department of Clinical and Experimental Medicine, Messina, Italy
 
17:00 - 18:00 A NOVEL MODIFIED LIPID TETRAD INDEX AS PREDICTOR OF PREMATURE CORONARY ARTERY DISEASE IN INDIANS  199
  S. Das1
1Maulana Azad Medical College, Department Of Biochemistry, New Delhi, India
 
17:00 - 18:00 CIRCULATING LIPOPROTEIN (A) [LP(A)] LEVELS AND RISK OF CARDIOVASCULAR DISEASE: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY  200
  R. Hoogeveen1, W. Sun1, V. Salim1, B. Christie1
1Baylor College of Medicine, Medicine, Houston, USA
 
17:00 - 18:00 THE ROLE OF Lp(a) LEVELS AND APOPROTEIN(a) PHENOTYPE IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN PATIENTS WITH CORONARY ARTERY DISEASE  201
  D. Labudovic1, K. Toseska-Trajkovska1, S. Alabakovska1, J. Bogdanska1, S. Jovanova 2
1Medical and Experimental Biochemistry, Department of ME Biochemistry, Skopje, FYR Macedonia
2University Clinic of Cardiology - Faculty of Medicine - Ss.Cyril and Methodius University in Skopje, University Clinic of Cardiology, Skopje, FYR Macedonia
 
17:00 - 18:00 LIPOPROTEIN(a) AND T-HELPER CELLS AS INDEPENDENT PREDICTORS OF RAPID PROGRESSION OF CAROTID ATHEROSCLEROSIS  202
  O. Afanasieva1, E. Pylaeva1, T. Arefieva 1, E. Klesareva 1, M. Afanasieva1, A. Potekhina2, A. Shchinova3, T. Balakhonova2, O. Pogorelova2, M. Tripoten 2, S. Pokrovsky1
1Russian Cardiology Research and Production Complex, Institute of Experimental Cardiology, Moscow, Russia
2Russian Cardiology Research and Production Complex, Institute of Clinical Cardiology, Moscow, Russia
3Lomonosov Moscow State University, Faculty of fundamental medicine, Moscow, Russia
 
17:00 - 18:00 POPULATION AND ASSAY THRESHOLDS FOR THE PREDICTIVE VALUE OF LIPOPROTEIN(A) FOR RISK OF CORONARY ARTERY DISEASE: THE EPIC-NORFOLK PROSPECTIVE POPULATION STUDY  203
  R. Verbeek1, S.M. Boekholdt2, R.M. Stoekenbroek1, G.K. Hovingh1, J.L. Witztum3, N.J. Wareham4, M.S. Sandhu5, K.T. Khaw5, S. Tsimikas6
1Academic Medical Center, Vascular medicine, Amsterdam, Netherlands
2Academic Medical Center, Cardiology, Amsterdam, Netherlands
3University of California San Diego, Endocrinology, La Jolla, USA
4University of Cambridge, Medical Research Council Epidemiology Unit, Cambridge, United Kingdom
5University of Cambridge, Public Health and Primary Care, Cambridge, United Kingdom
6University of California, Cardiology, La Jolla, USA
 
17:00 - 18:00 STATUS OF INFLAMMATION, ENDOTHELIAL ACTIVATION AND PROTHROMBOGENESIS AMONG NEGRITOS AND MALAYS WITH METABOLIC SYNDROME  204
  S.S. Mokhtar1, N.A. Mohd Mokhsin1, F. Mohd Nor1, S.A. Shaari1, H. Nawawi1,2, B.P. Hoh1,3, T. Rahman1,2
1Universiti Teknologi MARA, Faculty of Medicine, Sungai Buloh, Malaysia
2Universiti Teknologi MARA, Institute for Pathology- Laboratory and Forensic Medicine I-PPerForM, Selayang, Malaysia
3UCSI University, Faculty of Medicine and Health Science, Kuala Lumpur, Malaysia
 
17:00 - 18:00 ELEVATED LIPOPROTEIN(A) LEVELS RESULT IN A HIGH CARDIOVASCULAR RISK - A PROSPECTIVE ANALYSIS OF A LIPIDOLOGY OUTPATIENTS UNIT  205
  U. Schatz1, S. Fischer1, U. Julius1, S.R. Bornstein1, S. Tselmin1
1University Hospital / TU-Dresden, Dpt of Internal Medicine III, Dresden, Germany
 
17:00 - 18:00 PROFILE OF CIRCULATING miRNAs IN PATIENT WITH HIGH Lp(a) TREATED BY LDL/Lp(a) APHERESIS  206
  D. Dlouha1, J. Pitha1, Z. Eretova2, O. Viklicky 2, A. Parikova2
1Institute for Clinical and Experimental Medicine, Center for Experimental Medicine, Prague 4, Czech Republic
2Institute for Clinical and Experimental Medicine, Clinic of Nephrology, Prague 4, Czech Republic
 
17:00 - 18:00 FAMILIAL HYPERCHOLESTEROLEMIA (FH) WITH ELEVATED LIPOPROTEIN(a) (Lp(a)) LEVELS AND AGGRESSIVE CORONARY HEART DISEASE: A CASUISTIC APPROACH  207
  A. Dybvig1, A. Græsdal2
1, Sandefjord, Norway
2Vestfold Indremedisinske Senter, Vestfold Indremedisinske Senter, Sandefjord, Norway
 
17:00 - 18:00 LIPOPROTEIN(a) IS A PREDICTOR OF ONE-YEAR VEIN GRAFT OCCLUSIONS IN STABLE ANGINA PATIENTS RECEIVED LIPOPROTEIN APHERESIS FOR REFRACTORY HYPERCHOLESTEROLEMIA AFTER CORONARY ARTERY BYPASS GRAFTING  208
  R. Adzhiev1, M. Ezhov1, O. Afanasieva2, S. Pokrovsky2
1Russian Cardiology Research and Production Complex, Department of atherosclerosis, Moscow, Russia
2Russian Cardiology Research and Production Complex, Laboratory of atherosclerosis, Moscow, Russia
 
17:00 - 18:00 LIPOPROTEIN(A) LEVEL AS A PREDICTOR OF LONG-TERM CARDIOVASCULAR OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTIONS  209
  M. Mitroshkin1, M. Ezhov1, M. Safarova1, O. Afanasieva1, Y. Matchin1, S. Pokrovsky1
1Russian Cardiology Research and Production Complex, Department of atherosclerosis, Moscow, Russia
 
17:00 - 18:00 EFFECT OF NIACIN ON LIPOPROTEIN SUBFRACTIONS CONCENTRATION IN PATIENTS WITH ELEVATED LIPOPROTEIN(a)  210
  E. Utkina1, O. Afanasieva1, N. Artemieva1, M. Ezhov1, I. Adamova1, Y. Berestetskaya1, S. Pokrovsky1
1Russian Cardiological Research and Production Complex, Institute of Experimental Cardiology, Moscow, Russia
 
 
Community Search
Sign In

Sign In securely

Haven't registered yet?

Latest News
Featured Members

 
809 Laurel Street
San Carlos, CA 94070
650/995.3242